Prathyusha Durabaibu
Vermogen: 614 639 $ op 31-05-2026
Vermogen: 614 639 $ op 31-05-2026
Prathyusha Durabaibu is currently an Independent Director at Organogenesis Holdings, Inc. since 2021.
Formerly, Ms. Durabaibu was Controller at Pacific Biosciences of California, Inc. from 2010 to 2019 and Principal Financial Officer at Sangamo Therapeutics, Inc. from 2025 to 2026.
Education includes an undergraduate degree from Oxford Brookes University and an MBA from San Jose State University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-04-2026 | 198.219 ( 0,15% ) | 509 423 $ | 31-05-2026 | |
| 22-01-2026 | 482.645 ( 0,12% ) | 105 217 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ORGANOGENESIS HOLDINGS INC. | Directeur/Bestuurslid | 19-11-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Financieel Directeur/CFO | 03-02-2026 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Comptroller/Controller/Auditor | 01-03-2019 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures sequencing system products to help scientists to resolve genetically complex problems | Health Technology |
Oxford Brookes University
Oxford Brookes University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Jose State University
San Jose State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Organogenesis Holdings, Inc.
Organogenesis Holdings, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes regenerative medicines products for the advanced wound care and surgical and sports medicine markets | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau